Mainz Biomed B.V. Profile Avatar - Palmy Investing

Mainz Biomed B.V.

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product ca…

Medical - Diagnostics & Research
DE, Mainz [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
0.00% YoY
0.00% 3Yr
0.00% 5Yr
0.00% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of MYNZ's Analysis
CIK: 1874252 CUSIP: N5436L101 ISIN: NL0015000LC2 LEI: - UEI: -
Secondary Listings
MYNZ has no secondary listings inside our databases.